Clinical Trials on Female Reproductive Cancer in Japan
Total 1338 results
-
Takayuki YoshinoOno Pharmaceutical Co. LtdRecruiting
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
University of Texas Southwestern Medical CenterWithdrawnLocally Advanced Pancreatic AdenocarcinomaUnited States, Japan
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
National University Hospital, SingaporeSeverance Hospital; Wakayama Medical UniversityUnknownGastric CancerSingapore, Korea, Republic of, Japan
-
Eli Lilly and CompanyCompletedGastric CancerJapan, Korea, Republic of
-
Taiho Pharmaceutical Co., Ltd.Completed
-
PfizerActive, not recruitingA Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)Renal Cell CancerUnited States, Hungary, Spain, United Kingdom, Belgium, Korea, Republic of, Canada, Israel, Denmark, Australia, Italy, Japan, France, Austria, New Zealand, Romania, Russian Federation, Netherlands, Germany, Mexico, Sweden
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, Argentina, Belgium, Brazil, China, Poland, United Kingdom, Italy, Japan, Germany, Romania
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsJapan
-
M.D. Anderson Cancer CenterTerminatedBreast CancerUnited States, Japan
-
AbbVieGynecologic Oncology Group;Australia New Zealand Gynaecological Oncology...TerminatedOvarian Cancer | Ovarian NeoplasmUnited States, Australia, Brazil, Denmark, Israel, Japan, Korea, Republic of, New Zealand, Poland, Spain, United Kingdom
-
Aichi Cancer CenterUnknown
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaTaiwan, Korea, Republic of, Turkey, Spain, Thailand, Singapore, Japan, Canada, Malaysia, Poland, Italy, Romania
-
Eisai Co., Ltd.Completed
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Merck Sharp & Dohme LLCRecruitingMelanoma | Renal Cell Carcinoma | Non-Small Cell Lung CancerPoland, United States, Argentina, Chile, Japan, Australia, France, New Zealand, South Africa, Turkey
-
Taiho Pharmaceutical Co., Ltd.Yakult Honsha Co., LTDCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Eli Lilly and CompanyCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Translational Research Center for Medical Innovation...Completed
-
Eisai Co., Ltd.Completed
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedPancreatic CancerJapan
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Taiho Pharmaceutical Co., Ltd.Yakult Honsha Co., LTDCompletedGastric CancerJapan, Korea, Republic of
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Kyoto UniversityTerminated
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Translational Research Center for Medical Innovation...Kurosawa HospitalCompleted
-
Novartis PharmaceuticalsWithdrawnEndometrial CancerUnited States, Russian Federation, Germany, Singapore, Italy, Spain, France, Brazil, Canada, Japan, Poland, Turkey
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
SanofiActive, not recruiting
-
Translational Research Center for Medical Innovation...Kyoto Breast Cancer Research NetworkCompleted
-
Tohoku UniversityCompleted
-
Eisai Co., Ltd.Completed